Story perspectives

Trump Administration Slams FDA's Mail-Order Abortion Approval

1/30/2026

Summary

Trump Critiques Biden's Abortion Policy

U.S. President Donald Trump’s administration filed a court brief criticizing the Biden FDA's approval of mail-order abortions, arguing it endangers women's safety and undermines legal standards.
The brief asserts that the decision has caused significant harm to women and unborn children.
It raises concerns that men could coerce women into using these drugs.
The administration's stance reflects ongoing tensions over abortion access and regulatory authority.

Summary

Trump Seeks Abortion Pause

U.S. President Donald Trump’s administration asked a federal court to pause a Louisiana lawsuit restricting access to the abortion pill mifepristone while the Food and Drug Administration (FDA) reviews its safety.
The administration says pausing would avoid disrupting the FDA's regulatory process.
Anti-abortion activists are frustrated by Biden-era rules that facilitate mail-order access to mifepristone.
A hearing is set for February 24, 2026, to address these issues.

History

Historical Context

The 1973 Supreme Court ruling in Roe v. Wade legalized abortion nationwide, establishing a woman's right to choose while allowing states to regulate the procedure. This landmark decision arose from a challenge by Norma McCorvey, known as "Jane Roe," against Texas laws prohibiting abortion. Ongoing legal battles, such as those surrounding mifepristone, reflect the enduring conflicts over reproductive rights that began in the 1970s.

1 of 3

Trump Critiques Biden's Abortion Policy

U.S. President Donald Trump’s administration filed a court brief criticizing the Biden FDA's approval of mail-order abortions, arguing it endangers women's safety and undermines legal standards.
The brief asserts that the decision has caused significant harm to women and unborn children.
It raises concerns that men could coerce women into using these drugs.
The administration's stance reflects ongoing tensions over abortion access and regulatory authority.

1 / 3